Road Biology Environmental Protection Technology(688156)
Search documents
路德科技:关于控股子公司增资及变更法定代表人完成工商变更登记的公告
Zheng Quan Ri Bao· 2026-02-24 12:44
证券日报网讯 2月24日,路德科技发布公告称,公司子公司四川永乐路德生物科技开发有限公司(简 称"永乐路德")拟以增资扩股方式引入投资者。聚力杭实(杭州)股权投资合伙企业(有限合伙)(简 称"聚力杭实")拟现金出资3,700万元认购永乐路德新增注册资本3,700万元。公司就本次增资事项放 弃优先认购权。以上事项已经2025年12月22日召开的第五届董事会第七次会议审议通过。交易完成后, 永乐路德的注册资本由6,000万元增加至9,700万元,公司直接持有永乐路德的股权比例由66.0000% 变更为40.8248%,永乐路德仍属于公司合并报表范围内的控股子公司。同时,永乐路德因经营管理需 要对其法定代表人进行了变更。永乐路德法定代表人由胡卫庭变更为季光明。截至本公告披露日,永乐 路德已收到聚力杭实缴付的增资款3,700万元,并于近日完成了本次增资扩股事项及法定代表人变更事 项的工商变更登记手续,取得了由古蔺县市场监督管理局换发的《营业执照》。 (文章来源:证券日报) ...
路德科技(688156) - 关于控股子公司增资及变更法定代表人完成工商变更登记的公告
2026-02-24 08:00
路德生物环保科技股份有限公司 证券代码:688156 证券简称:路德科技 公告编号:2026-011 一、基本情况 路德生物环保科技股份有限公司(以下简称"公司"或"路德科技")子公司四川 永乐路德生物科技开发有限公司(以下简称"永乐路德")拟以增资扩股方式引入投 资者。聚力杭实(杭州)股权投资合伙企业(有限合伙)(以下简称"聚力杭实") 拟现金出资 3,700 万元认购永乐路德新增注册资本 3,700 万元。公司就本次增资事 项放弃优先认购权。以上事项已经 2025 年 12 月 22 日召开的第五届董事会第七次 会议审议通过。 交易完成后,永乐路德的注册资本由 6,000 万元增加至 9,700 万元,公司直接 持有永乐路德的股权比例由 66.0000%变更为 40.8248%,永乐路德仍属于公司合并 报表范围内的控股子公司。具体内容详见公司于 2025 年 12 月 23 日披露于上海证 券交易所网站(www.sse.com.cn)的相关公告(公告编号:2025-045、2025-049)。 同时,永乐路德因经营管理需要对其法定代表人进行了变更。永乐路德法定 代表人由胡卫庭变更为季光明。 二、完成变更后 ...
路德科技饲料销量大增,与国投聚力合作深化
Jing Ji Guan Cha Wang· 2026-02-12 09:48
Group 1 - The core viewpoint of the news is that Lude Technology is expected to see a significant increase in its bio-fermented feed sales, projected to grow over 50% year-on-year by 2025, with both production lines at the Bozhou factory operating at high capacity [1] - The company has signed a strategic cooperation agreement with Guotou Juliy to deepen collaboration in the research and industrialization of microbial protein and other feed proteins, indicating a positive outlook for the downstream cattle breeding cycle [1] Group 2 - In the recent stock performance, Lude Technology's share price increased from 19.14 yuan to 19.70 yuan over a 7-day period, reflecting a cumulative increase of 2.93% with a price fluctuation of 5.34% [2] - The capital flow indicates a net outflow of 251.48 million yuan on February 9 and a further net outflow of 180.10 million yuan on February 11, with the financing balance as of February 11 standing at 9632.73 million yuan, suggesting stable trading activity but a trend of net capital outflow [2]
路德科技公布国际专利申请:“一种固化材料及其应用”
Sou Hu Cai Jing· 2026-02-07 21:47
Group 1 - The core viewpoint of the article highlights that Lude Technology (688156) has announced an international patent application for a solidification material and its applications, with the application number PCT/CN2024/108665 and an international publication date set for February 5, 2026 [1] - Lude Technology has published a total of two international patent applications in the current year [1] - In the first half of 2025, the company invested 7.2746 million yuan in research and development, reflecting a year-on-year increase of 9.52% [1]
路德科技(688156) - 关于控股子公司向关联方借款暨关联交易的公告
2026-02-03 09:45
证券代码:688156 证券简称:路德科技 公告编号:2026-010 路德生物环保科技股份有限公司 关于控股子公司向关联方借款暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 路德生物环保科技股份有限公司 路德生物环保科技股份有限公司(以下简称"公司"或"路德科技")子公 司绍兴路德环保技术有限公司(以下简称"绍兴路德")拟向公司关联方浙江林盛 建设发展有限公司(以下简称"林盛建设")借款 500.00 万元。该笔借款年利率 为 3.00%。借款期限自 2026 年 2 月 4 日起,至 2027 年 2 月 5 日止,借款时间共 1 年,实际起算时间以借款支付到账之日为准,还款期限相应顺延。 林盛建设为公司关联方,绍兴路德为公司控股子公司。本次绍兴路德向 林盛建设借款事项构成关联交易。本次关联交易不构成重大资产重组。 一、关联交易概述 基于绍兴路德的自身资金需求,绍兴路德向林盛建设申请借款 500.00 万元。 路德科技持有绍兴路德 51.0000%股份,林盛建设持有绍兴路德 49.00 ...
路德科技(688156) - 第五届董事会第九次会议决议公告
2026-02-03 09:45
路德生物环保科技股份有限公司 (一)审议通过《关于控股子公司向关联方借款暨关联交易的议案》 公司子公司绍兴路德环保技术有限公司拟向公司关联方浙江林盛建设发展有 限公司借款 500.00 万元。该笔借款年利率为 3.00%。 路德生物环保科技股份有限公司 第五届董事会第九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 路德生物环保科技股份有限公司(以下简称"公司")第五届董事会第九次 会议于 2026 年 2 月 3 日以现场结合通讯方式召开,本次会议通知已于 2026 年 1 月 30 日以电子邮件的方式发出。本次会议应出席董事 7 名,实到 7 名,本次会议 由董事长季光明先生主持。会议的召集、召开和表决情况符合《中华人民共和国 公司法》(以下简称"《公司法》")等有关法律、法规及《路德生物环保科技 股份有限公司章程》(以下简称"公司章程")的规定,形成的决议合法、有效。 二、董事会会议审议情况 参会董事审议并以投票表决方式通过了下列议案: 证券代码:688156 证券简称:路德科 ...
路德科技(688156) - 第五届董事会第九次会议决议
2026-02-03 09:45
路德生物环保科技股份有限公司 第五届董事会第九次会议决议 一、会议时间:2026年2月3日 二、会议地点:公司会议室 三、与会董事:应到董事 7 人,出席会议董事 7 人。会议的召开符合《公司 法》及本公司章程的规定。 四、决议事项: 二、董事会会议审议情况 参会董事审议并以投票表决方式通过了下列议案: (一) 审议通过《关于控股子公司向关联方借款暨关联交易的议案》 -具体内容详见同日披露于上海证券交易所网站(www.sse.com.cn)的《关于 控股子公司向关联方借款暨关联交易的公告》(公告编号: 2026-010)。 表决结果:同意7票,反对0票,弃权0票。 本次会议无其他议案。 路德生物环伊 972 (本页无正文,为《路德生物环保科技股份有限公司第五届董事会第九次会议决 议》之签字页) 出席会议董事: 沈水宝 季光明 季维宽 沈水宝 旅 鹰天文 蒋天文 史 永 雄 陈 发 郑应家 公司子公司绍兴路德环保技术有限公司拟向公司关联方浙江林盛建设发展 有限公司(以下简称"林盛建设")借款 500.00 万元。该笔借款年利率为 3.00%。 (本页无正文,为《路德生物环保科技股份有限公司第五届董事会第九次会议 ...
路德科技2025年归母净利润预计同比亏损扩大 两座生物发酵饲料新厂已实现产品线盈利
Mei Ri Jing Ji Xin Wen· 2026-01-30 00:17
Core Viewpoint - Lude Technology (SH688156) anticipates a significant increase in losses for the fiscal year 2025, with projected net losses of approximately 63 million yuan and 66.5 million yuan for net profit after deducting non-recurring items, compared to losses of 56.55 million yuan and 59.67 million yuan in 2024, respectively [1][2][3] Group 1: Financial Performance - The expected losses for 2025 are attributed to high fixed costs from three new factories that began operations in Q4 2024, leading to a decline in gross margin for the biopharmaceutical feed business [1][3] - The company reported that two of the new factories achieved profitability in September 2025, contributing to a projected 50% year-on-year increase in sales volume for the biopharmaceutical feed business [2][3] - Despite the anticipated losses, Lude Technology expects a net cash flow from operating activities of approximately 60 million yuan for the entire year of 2025 [6] Group 2: Operational Challenges - The increase in losses is also linked to higher depreciation and amortization costs from new fixed assets, which are expected to rise by around 10 million yuan in 2025 [4] - The company faces additional financial strain from increased impairment losses on contract assets and accounts receivable in its inorganic waste treatment business, totaling approximately 30 million yuan [4] Group 3: Strategic Initiatives - Lude Technology has entered into a strategic cooperation agreement with Guotou Juliy Investment Management Co., aiming to focus on the biopharmaceutical feed business and reduce investments in the environmental waste sector [5] - The company has completed capital increases for its subsidiaries in the biopharmaceutical feed sector, amounting to a total investment of 117 million yuan [4]
路德科技:关于变更持续督导保荐代表人的公告
Zheng Quan Ri Bao· 2026-01-29 14:19
Group 1 - The core point of the article is the announcement by Lude Technology regarding the change in its continuous supervision representatives due to the departure of Zhang Yiwei [2] - Guotou Securities has appointed Fan Changjiang to take over the continuous supervision work [2] - The company's continuous supervision representatives have been changed to Huang Jun and Fan Changjiang [2]
路德科技(688156.SH)发预亏,预计2025年年度归母净亏损6300万元左右
智通财经网· 2026-01-29 13:20
Core Viewpoint - The company, Lude Technology (688156.SH), anticipates a net loss of approximately 63 million yuan attributable to shareholders for the fiscal year 2025, despite ongoing efforts to optimize product and customer structure, expand sales channels, and enhance cost efficiency [1] Group 1: Financial Performance - The expected net profit for 2025 is projected to be around -63 million yuan [1] - The company is experiencing a decline in gross margin for its liquor lees bio-fermented feed business compared to the same period last year due to high fixed cost amortization pressures [1] Group 2: Business Operations - The company is focusing on improving production efficiency at its new bio-fermented feed plants, which have shown steady growth in capacity, sales, and revenue [1] - Sales volume for bio-fermented feed is expected to increase by over 50% year-on-year in 2025 [1] - Three new plants that commenced production in Q4 2024 are ramping up well, with two plants achieving product line profitability starting September 2025 [1]